Simultaneous Interference with HER1/EGFR and RAC1 Signaling Drives Cytostasis and Suppression of Survivin in Human Glioma Cells in Vitro

Erstveröffentlichung
2017
Metadata only
Search for full text
Wissenschaftlicher Artikel


Authors
Karpel-Massler, G.
Westhoff, M. -A.
Kast, R. E.
Dwucet, A.
Karpel-Massler, S.
et al.
Institutions
UKU. Klinik für Neurochirurgie
UKU. Klinik für Kinder- und Jugendmedizin
Published in
Neurochemical Research ; 42 (2017), 5. - S. 1543-1554. - ISSN 0364-3190. - eISSN 1573-6903
Link to publication
https://dx.doi.org/10.1007/s11064-017-2213-0
Funding information
young investigator's grant by Ulm Medical School
Dr. Mildred Scheel foundation of the German Cancer Aid
Keywords
HER1/EGFR; RAC1; Survivin; Glioma; Cytostasis; Apoptosis; Synergy; diagnosed glioblastoma-multiforme; growth-factor receptor; breast-cancer cells; phase-2 trial; down-regulation; temozolomide; erlotinib; inhibition; induction
Dewey Decimal Group
DDC 610 / Medicine & health
Metadata
Show full item record